Giacomini to lead $15.1 million in research funding to improve the use of drugs in individuals

Giacomini to lead $15.1 million in research funding to improve the use of drugs in individuals

Kathy Giacomini, PhD, co-chair of the UCSF Department of Bioengineering and Therapeutic Sciences and an expert in the field of pharmacogenomics, is leading two research projects funded by two grants totaling $15.1 million over the next five years to expand research into how genes affect an individual's response to medication and to strengthen a global network of researchers involved in these efforts. The grants are the largest portion of a $161.3 million total effort by the National Institutes of Health to expand a national collaboration of scientists known as the Pharmacogenomics Research Network with the goal of paving the way for personalized medicine.

More:

UCSF receives $15 million to advance personalized medicine


About the School: The UCSF School of Pharmacy is a premier graduate-level academic organization dedicated to improving health through precise therapeutics. It succeeds through innovative research, by educating PharmD health professional and PhD science students, and by caring for the therapeutics needs of patients while exploring innovative new models of patient care. The School was founded in 1872 as the first pharmacy school in the American West. It is an integral part of UC San Francisco, a leading university dedicated to promoting health worldwide.